A031501

Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation
Contact phone
517.364.2835
Principal investigator
Gordan Srkalovic MD, PhD
Trial Category
Cancer
Trial SubCategory
Bladder/Urothelial
Webform